PK and Safety Evaluation Study of SAP-001 in Adult Subjects With Normal and Impaired Renal Function

Summary

This is a multicenter, open-label, non-randomized, parallel-group, single-dose, 2-part, adaptive study in which up to approximately 32 adult subjects will be enrolled in one of 4 groups (8 subjects per group) with varying degrees of renal function.

Timeline

Start

2024-04-24

Primary completion

2025-01-17

Completion

2025-04-28

Drugs

Indications